Salona Global Medical Device (TSE:EVMT) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Evome Medical Technologies reported a positive financial performance in the third quarter of 2024, achieving $424,000 in adjusted EBITDA and reducing debt by $1.4 million. The company has also expanded its product offerings by launching a new distribution company and appointing Bill Garbarini as the Chief Operating Officer. These strategic moves are part of Evome’s efforts to stabilize its business and strengthen its market position.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.